je.st
news
Tag: presents
AIA Presents 2014 Wings of Liberty Award to Representative Harold "Hal" Rogers
2014-09-18 06:00:00| Industrial Newsroom - All News for Today
On September 18, Aerospace Industries Association (AIA) presented its Wings of Liberty Award to Representative Harold "Hal" Rogers (R-KY) to recognize his longtime support of aerospace and defense industry. AIA President and CEO Marion C. Blakey, citing his tenure as "a tremendous leader of our cause," said Rogers was "richly deserving of this year’s award" and noted his Appropriations leadership as well as his emphasis on putting national security first. This story is related to the following:Trade Associations
Tags: award
presents
representative
wings
Siemens Presents Onshore Innovations at WindEnergy Trade Fair in Hamburg
2014-09-18 06:00:00| Industrial Newsroom - All News for Today
WindEnergy 2014 in Hamburg (September 23-26, 2014): Hall B6, Booth 362<br /> <br /> • Premiere for new wind turbine optimized for sites with low wind speeds<br /> • Live opening of new remote diagnostics center as feature event for visitors<br /> <br /> Ready for new markets: Under the banner slogan “Green Energy. Made in Hamburg”, Siemens Energy is presenting its newest products at the wind power trade fair "WindEnergy 2014" in Hamburg, Germany from September 23 through ...This story is related to the following:Green & CleanSearch for suppliers of:
Tags: trade
fair
presents
hamburg
Merck Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes
2014-09-17 15:31:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Omarigliptin significantly reduced HbA1c levels compared to placebo WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development program for omarigliptin, Mercks investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes. In a study in Japanese patients, omarigliptin provided comparable efficacy and tolerability to Mercks once-daily DPP-4 inhibitor JANUVIA (sitagliptin) 50 mg, which is the standard starting dose for sitagliptin in Japan. Language: English Contact: MerckMedia:Pam Eisele, +1 (267) 305-3558Michael Close, +1 (267) 305-1221 or +1 (310) 617-1067orInvestors:Justin Holko, +1 (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Renault presents the 235 mpg EOLAB prototype; plug-in Z.E. Hybrid; targeting production
2014-09-17 12:30:33| Green Car Congress
Tags: production
presents
hybrid
renault
Belden Presents New Routing Software for Maximum Network Availability
2014-09-17 06:10:46| Industrial Machines - Topix.net
Belden Inc., a global leader in signal transmission solutions for mission-critical applications, is offering a new, free software version that - for the first time - has routing functionality for the Hirschmann switches in the Rail Switch Power , Rail Switch Power Expandable and MICE Switch Power families. The Hirschmann Operating System 4.0 supports various security mechanisms, comprehensive management and diagnostic methods, precise time synchronization, and redundancy protocols, thus ensuring maximum network availability.
Tags: software
network
maximum
availability
Sites : [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] next »